449 Rituximab As Second Line Treatment For Adult Immune Thrombocytopenia (ITP)

Date : Déc 2013

Auteur : Waleed Ghanima, Abderrahim Khelif, Neila Benromdhan, Anders Waage, Geir E. Tjonnfjord, Marc Michel, Darne Bernadette, Johannes Kahrs, Andre Holme

Titre : 449 Rituximab As Second Line Treatment For Adult Immune Thrombocytopenia (ITP): A Multicentre, Randomized, Double Blind, Placebo-Controlled Study – The Ritp Study (NCT00344149)

Référence : 55th ASH (The American Society of Hematology) Annual Meeting & Exposition

December 7-10, 2013, New Orleans, LA

Lien Web : Lien ici 

Leave a Comment